TrialClinical and translational science2025

Low Proarrhythmic Risk of Imetelstat, a Novel Oligonucleotide Telomerase Inhibitor: A Translational Analysis.

Ashley L Lennox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.